Does dosage of triamcinolone injection affect outcome of trigger finger treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180820004

Enrollment

Registered

2018-08-20

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

5 mg triamcinolone injection,10 mg triamcinolone injection

Experimental Drug,Experimental Drug

5 mg triamcinolone,10 mg triamcinolone

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -age more than 18 -trigger finger gr I-III

Exclusion criteria

Exclusion criteria: -symptoms more than 6 months -previous steroid injection -allergy to triamcinolone and lidocain -Dm, autoimmune or inflamatory arthritis -history of trauma of affected digits

Design outcomes

Primary

Measure	Time frame
effectiveness 3 month no pain and triggering	—

Secondary

Measure	Time frame
Pain at injection immediately VAS	—

Contacts

Public Contactpossawat rujiraphum

lerdsin hospital

maninger_sk@hotmail.com085-147-3926

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026